NKI researchers discover three new resistance mechanisms against commonly used anti-cancer drugs
commonly used anti-cancer drugs doxorubicin and e toposide. In The Netherlands alone, thousands of patients a year are treated with one of these drugs. But they don't always work well for every patient. The new discovery might help predict whether…